112 related articles for article (PubMed ID: 2675195)
21. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
Katsuura G; Itoh S; Hsiao S
Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens.
Crawley JN
Ann N Y Acad Sci; 1994 Mar; 713():138-42. PubMed ID: 8185154
[No Abstract] [Full Text] [Related]
23. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion.
Crawley JN
Synapse; 1989; 3(4):346-55. PubMed ID: 2740993
[TBL] [Abstract][Full Text] [Related]
24. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
25. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
Debonnel G; de Montigny C
Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
[TBL] [Abstract][Full Text] [Related]
26. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
Barnes JC; Costall B; Domeney AM; Naylor RJ
Psychopharmacology (Berl); 1986; 89(3):311-6. PubMed ID: 3088656
[TBL] [Abstract][Full Text] [Related]
27. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
Vaccarino FJ; Rankin J
Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
[TBL] [Abstract][Full Text] [Related]
28. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum.
Austin MC; Kalivas PW
Jpn J Pharmacol; 1989 Aug; 50(4):487-90. PubMed ID: 2779013
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
Costall B; Domeney AM; Naylor RJ
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat.
Kirouac GJ; Ganguly PK
Brain Res; 1995 Aug; 689(2):245-53. PubMed ID: 7583328
[TBL] [Abstract][Full Text] [Related]
31. Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.
Belcheva I; Belcheva S; Petkov VV; Petkov VD
Neuropharmacology; 1994 Aug; 33(8):995-1002. PubMed ID: 7845556
[TBL] [Abstract][Full Text] [Related]
32. Chronic effects of nicotine on mesolimbic dopaminergic system in rats.
Fung YK; Lau YS
Pharmacol Biochem Behav; 1992 Jan; 41(1):57-63. PubMed ID: 1347177
[TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection.
Fuxe K; Andersson K; Locatelli V; Agnati LF; Hökfelt T; Skirboll L; Mutt V
Eur J Pharmacol; 1980 Oct; 67(2-3):329-31. PubMed ID: 7461038
[No Abstract] [Full Text] [Related]
34. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
Weiss F; Ettenberg A; Koob GF
Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
[TBL] [Abstract][Full Text] [Related]
35. Effects of methamphetamine, dopamine and noradrenaline administered into the nucleus accumbens of rats discriminating subcutaneous methamphetamine.
Ando K; Miyata H; Yanagita T
Jpn J Pharmacol; 1994 Jan; 64(1):35-40. PubMed ID: 8164391
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
Kihara T; Ikeda M; Matsubara K; Matsushita A
Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
[TBL] [Abstract][Full Text] [Related]
37. Dopamine increase in the nucleus accumbens of rats exposed to high pressure.
Abraini JH; Rostain JC
Neuroreport; 1991 May; 2(5):233-5. PubMed ID: 1655102
[TBL] [Abstract][Full Text] [Related]
38. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
Kalivas PW; Nemeroff CB; Prange AJ
Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859
[TBL] [Abstract][Full Text] [Related]
39. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.
Rubin EH; Wooten GF
Psychopharmacology (Berl); 1984; 84(2):217-20. PubMed ID: 6438680
[TBL] [Abstract][Full Text] [Related]
40. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
Weiss F; Tanzer DJ; Ettenberg A
Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
